San Diego, California
April 17, 2026 – April 22, 2026
Visit Discovery Life Sciences at Booth #3038 during the AACR Annual Meeting, April 17–22, 2026, at the San Diego Convention Center.
The AACR Annual Meeting is the premier gathering for the cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to share groundbreaking advances in cancer science and medicine. From population science and prevention to cancer biology, translational and clinical studies, survivorship, and advocacy, this event showcases the work of leading minds from institutions worldwide. Don’t miss the opportunity to connect with Discovery Life Sciences and learn how we’re driving innovation in cancer research.
Stop by Booth 3038 to hear Discovery Life Sciences and our partners present a series of 15-minute flash talks at this year’s AACR Annual Meeting.
| Monday, April 20, 2026 | |
| 11:15 a.m. | PhenoScout AI – Turn-key Analysis for Spatial Biology Fabian Schneider, Ph.D., Senior Product Manager, Mindpeak |
| 1:30 p.m. | Advanced Tumoroid Models for Studying the Tumor Microenvironment Shawn Fahl, Ph.D., VP Laboratory Operations CP and RD, Discovery Life Sciences |
| 3:30 p.m. | Leveraging Proteomics for Novel Biomarker Discovery Olink |
| Tuesday, April 21, 2026 | |
| 11:15 a.m. | Tumoroid Technical Q&A Colin Paul, Ph.D., R&D Staff Scientist, Thermo Fisher Scientific Shawn Fahl, Ph.D., VP Laboratory Operations CP and RD, Discovery Life Sciences |
| 1:30 p.m. | Simplifying Multiplex IF Mark Burton, Product Specialist, Life Sciences, Leica Biosystems |
| 3:30 p.m. | Beyond Mutations: Rapid cfDNA Assay Development for Quantitative Gene Expression and Tumor Phenotyping Jim Davison, Director Translational Genomics, GeneCentric Nripesh Prasad, VP Scientific and Tech Development, Discovery Life Sciences |
| April 19 | 2:00 p.m. – 5:00 p.m. | Poster #825 | Bone marrow from acute myeloid leukemia (AML) and multiple myeloma (MM) patients can be used to evaluate target expression and on-target efficacy for novel antibody drug conjugates (ADCs) Coranna Akdemirbey, Research Associate, Cell Biology, Discovery Life Sciences |
| April 22 | 9:00 a.m. – 12:00 p.m. | Poster #7671 | Integrated proteogenomics of primary tumoroid models for precision Dr. Shawn Fahl, VP Cell Biology, Discovery Life Sciences |
| April 22 | 9:00 a.m. – 12:00 p.m. | Poster #7389 | Evaluation of tumor-infiltrating T cells across solid tumor indications Dr. Shawn Fahl, VP Cell Biology, Discovery Life Sciences |
| April 22 | 9:00 a.m. – 12:00 p.m. | Poster #7269 | Development and Validation of an Optimized, Bead-Based Dual Nucleic Acid Extraction Method for High-Yield Genomic Profiling of Scarce FFPE Tumor Specimens Dr. Nripesh Prasad, VP, Scientific & Technical Development, Discovery Life Sciences |
| April 22 | 9:00 a.m. – 12:00 p.m. | Poster #LB463 | Exploring the molecular landscape of ovarian cancer through immunohistochemistry multi-marker prevalence screening Eileen Black, Scientific Writer & Data Analyst, Discovery Life Sciences |
| April 22 | 9:00 a.m. – 12:00 p.m. | Poster #LB466 | Scalable, digitally enabled FISH workflows for high-confidence HER2 and genomic biomarker assessment in precision oncology Brigham Rhoads, Scientific Project Manager, Discovery Life Sciences |
| April 22 | 9:00 a.m. – 12:00 p.m. | Poster #LB465 | Establishing Quantitative Image Analysis Driven Multiplex Immunofluorescence Panels for Retrospective Clinical Research Salome Tchotorlishvili, Scientific Project Manager, Discovery Life Sciences |
*Not affiliated with or endorsed by AACR
